HOUSE_OVERSIGHT_026761.jpg

Swedish American Group Focuses On Cancer, Autoimmune Diseases At... _https://www.forbes.com/sites/genemarcial/20 17/09/09/swedish-american... Forbes / Investing / #StockWatch SEP 9, 2017 @ 05:48 PM 729@® 12 Stocks to Buy Now Swedish American Group Focuses On Cancer, Autoimmune Diseases At Life Science Summit Gene Marcial, CONTRIBUTOR . | have an insider's take on Wall Street FULL BIO VW Opinions expressed by Forbes Contributors are their own. Respected and acclaimed as rock stars in the arcane universe of life sciences, global scientists converged in Stockholm in late August this year for the annual Swedish American Life Science Summit (SALSS) meeting, where they unveiled and dissected revolutionary health care platforms. Among them are the use of robotics in surgery, how nanotechnology may make us "forever young,” applications of space technology in life sciences, and the “Moonshot” cancer program initiated by former Vice President Joseph Biden. Without doubt, global investors are closely watching organizations such as SALSS to discover the latest innovations and discoveries in life Shutterstock science. This area is replete with groups deeply involved in original research. So one of the major topics discussed at the SALSS conference was “impact investing,” or why investors should pay closer attention to investing in life science. “In today’s world with an aging population, we observe a higher occurrence of chronic diseases, such as cancer and autoimmune conditions,” noted Hans Straberg, chairman of Atlas Copco, and former CEO of Electrolux. “So Big Pharma and the industry are looking beyond the chemical and biologically derived molecules.” And as universities and small startups have taken the lead in R&D investments, "Big Pharma is very much dependent on collaborating with them, or acquiring their technologies,” he argued. Today Big Pharma has a “really strong position” in life sciences and are Looking for "new blockbusters to replace current stars that are coming off-patent,” he said. The current focus, added Straberg, is “very much on finding cures for diseases like cancer, autoimmunity, allergy and infection,” and employing various new technologies. So new ideas to address a variety of serious medical issues have always attracted medical luminaries to SALSS, and at this year’s conference, the speakers included Biden Cancer Initiative Executive Director Gregory Simon, Nobel Foundation chairman Dr. Carl Henrik Heldin, European Federation of Pharmaceutical Industries Director-General Richard Bergstrom, and Microsoft Healthcare's chief development officer Mathias Ekman. Also among the expert speakers were Pfizer executive vice president and chief of the company’s worldwide research development Dr. Michael Dolsten, Secretary-General of the Royal Swedish Academy Life Sciences' Dr. Goran Hansson, Google Healthcare and Cloud business manager Ebba Kraemer, China Kindstar Global Diagnostics CEO Shiang Huang, AVRA Medical Robotics founder and CEO Alen York, expert in diabetes-related issues and CEO of Lyfebulb Dr. Karin Hehenberger, and the founder and former chairman of Human Genome Sciences and currently chairman of ACCESS Health International Dr. William A. Haseltine. Recommended by Forbes MOST POPULAR a! TRENDING ON FACEBOOK The Inside Story of Marriott's High-Seas The 10 Most Dangerous Rescue After Irma US. Cities Stranded 620 Hotel... “Throughout the years, Swedish research and innovation have led the way to disruptive changes within medicine, which has resulted in an immense impact on people’s lives and great value for society,” argued Dr. Goran K. Hansson, secretary general of The Royal Swedish Academy of Sciences. Today, “we see an increased interest of foreign capital in Swedish Life Science, which the Swedish government embraces,” he said. Swedish Life Science players, he added, "look for international expansion 1 of 2 9/13/2017, 8:01 PM HOUSE_OVERSIGHT_026761